際際滷

際際滷Share a Scribd company logo
	 Adult male Sprague-Dawley rats (10 weeks of age) were pre-implanted with cortical electrodes.
	 Rats were given lithium chloride (127 mg/kg) followed by pilocarpine (50 mg/kg) to induce SE.
	 SE was first identified by presence of large amplitude slow wave EEG activity and then behaviorally
using the Racine scale. Racine stage 3 seizures were used as the time-marker for SE onset and
subsequent treatment.
	 GNX and diazepam (DZP) were administered
via IV bolus injection 15 min after detection
of SE onset. In combination studies, DZP was
administered just prior to GNX.  
	 Seizure magnitude and duration were
measured by EEG recordings. EEG power
(mV2/Hz) was calculated by fast Fourier
Transform, (FFT) in 1 Hz frequency bins from
1 to 96 Hz using ICELUS software. Frequency
ranges analyzed:
o	 Delta		 	 	 0  5 Hz
o	 Theta		 	 	 5  10 Hz
o	 Beta 		 	 	 10  30 Hz
o	 Gamma-1		 30  50 Hz
o	 Gamma-2		 50  70 Hz
o	 Gamma-3 	 70  96 Hz
	 EEG power values for each animal were
normalized by subtracting the baseline value from all subsequent values.
	 EEG power data were evaluated by 2-way ANOVA (treatment and time period) at each frequency
range using Prism Graphpad (version 6). Post-hoc analysis consisted of Holms-Sidak multiple
comparison tests, with significance set at P< 0.05.   
	 Ganaxolone (GNX) is the 3硫-methylated analog of the naturally occurring neurosteroid
allopregnanolone that is being developed for the treatment of status epilepticus (SE).
	 SE is a severe, life-threatening epileptic condition that is currently treated with benzodiazepines
to control SE followed by standard antiepileptic drugs such as phenytoin and then, if needed, by
administration of general anesthetics such as propofol.
 	 Patients with SE become progressively refractory to treatment over time. Moreover, more than
30% of SE patients are resistant to aggressive benzodiazepine administration.
 	 The rat lithium-pilocarpine model of SE is a clinically translatable model of this condition. Rats
subjected to experimental SE are refractory to benzodiazepine if treatment is initiated  15 min
after seizure onset; thus modeling a treatment resistant form of SE.
 	 GNX elicits its antiepileptic activity through positive allosteric modulation of both the synaptic
and the extrasynaptic GABAA receptors, unlike benzodiazepines which only modulate the
synaptic receptors.
 	 The current studies were designed to evaluate the combination antiepileptic effects of GNX with
diazepam in a benzodiazepine resistant SE paradigm.
Ganaxolone and Diazepam Administered IV Produce a Synergistic Antiepileptic
Effect in a Treatment Refractory Model of Status Epilepticus
Michael S. Saporito, PhD1, John A. Gruner, PhD2, Julia Tsai, PhD1, and Albena Patroneva, MD1.
1Marinus Pharmaceuticals, Inc, Radnor, PA, United States, 19087; 2 Melior Discovery, Inc. Exton, PA.
	 We have previously demonstrated that GNX when administered alone 15 min after SE onset elicits  a
complete block of SE at dose-levels of >12 mg/kg
	 Diazepam is inactive up to dose-levels of 10 mg/kg when administered >15 min after SE onset
	 When administered in combination 15 min after SE onset, DZP (5 mg/kg) and GNX (6 mg/kg) elicit a
complete block of pilocarpine induced seizures.
	 The pharmacokinetics of GNX and diazepam were identical when administered alone or in
combination indicating that neither drug affected the pharmacokinetic disposition of the other.
	 The data suggest that this synergistic enhancement of antiepileptic activity occurred at the level of
the GABAA receptor.
	 GNX administered alone in a dose-escalation fashion elicits EEG changes similar to that of propofol.
	 These data have clinical implications in the treatment of SE when GNX is to be administered to
patients who are or have been treated with benzodiazepines.
Skull Image
From Watson,
The Rat
anchor
screw
(sinus)
Frontal cortex
electrodes
3mm ant.
to Bregma
2.5mm lateral
Hippocampal
Electrodes
4mm post.
to Bregma
3mm lateral
Skull
sutures
anchor
screw
(vertex)
EEG
Ch1
Ch2
Neck
Muscles
InterauralLine
Lambda
Bregma
Bregma
Figure 1. Electrode Placement
Figure 2. Status epilepticus was induced by administration of lithium and pilocarpine. DZP (5 mg/kg; IV) or GNX were
administered 15 minutes after SE onset. For combinations, DZP and GNX were administered sequentially. Seizures were
measured by EEG response.  Data are expressed as a EEG power (Log mV2/Hz). Data represent the 10-30 Hz frequency
range. Data were analyzed by two-way ANOVA followed by a post-hoc Dunnetts test.  *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 from vehicle control.
Figure 2. Ganaxolone Combined with Diazepam Elicits a Synergistic Antiepileptic Effect in
Status Epilepticus
0 2 4 6
-1
0
1
2
Time Relative to SE Onset (hrs)
EEGPower
(LogmV2/Hz)
DZP (5 mg/kg)
Vehicle
Treatment
0 2 4 6
-1
0
1
2
Time Relative to SE Onset (hrs)
EEGPower
(LogmV2/Hz)
Vehicle
DZP (5 mg/kg) + GNX (3 mg/kg)
DZP (5 mg/kg) + GNX (6 mg/kg)
Treatment
**
*
**** ****
**
***
0 2 4 6
-1
0
1
2
Time Relative to SE Onset (hrs)
EEGPower
(LogmV2/Hz)
GNX (3 mg/kg)
GNX (6 mg/kg)
Vehicle
Treatment
SE-onset
Vehicle
Pilocarpine Treatment
Diazepam (5 mg/kg)
Ganaxolone (6 mg/kg)
Diazepam (5mg/kg)
+ Ganaxolone (6 mg/kg) SSSSSE-onset
EEG Traces SE-onset and Treatment
Figure 3. Representative EEG
traces of vehicle, diazepam
alone (5 mg/kg), GNX alone
(6 mg/kg) or diazepam and
ganaxolone in combination
Figure 4.  Diazepam (5 mg/kg) and GNX (6 mg/kg) pharmacokinetics (IV) were measured alone and in combination.
For combination, GNX was administered immediately after DZP.  Plasma levels were measured by LC/MS/MS.  
Predose
3 mg/kg
9 mg/kg
15 mg/kg
24 mg/kg
30 mg/kg
Propofol
6 sec
Ganaxolone
Figure 5. In order to evaluate
the effects of GNX on normal
awake rats, the drug was
administered at 3 mg/kg
(bolus; IV) every 3 minutes.  
EEG signal was measured
continuously for 6 hours.
EEG traces represent 6
seconds beginning 2 min
after the injection.  EEG
changes are consistent with
anesthetic effects and are
first detected after the 3rd
administration.
Figure 3. Diazepam and Ganaxolone Produce a Synergistic Antiepileptic Response
Figure 4. Ganaxolone and Diazepam Pharmacokinetics Were Not Altered by Co-administration
Figure 5. Ganaxolone Shows Similar Effects to Propofol on EEG
OVERVIEW
SUMMARY AND CONCLUSIONS
0 20 40 60 80 100
0
500
1000
1500
2000
2500
Diazepam Pharmacokinetics
Time (min)
Diazepam(ng/mL)
DZP (5 mg/kg)
GNX (6 mg/kg) + DZP (5 mg/kg)
0 20 40 60 80 100
0
1000
2000
3000
4000
Ganaxolone Pharmacokinetics
Time (min)
GNXLevels(ng/ml)
GNX (6 mg/kg)
GNX (6 mg/kg) + DZP (5 mg/kg)
METHODS

More Related Content

What's hot (20)

PPTX
Evaluation of anti epileptic drugs practical
Akshil Mehta
PPT
Gralise (Gabapentin ER)
KyleAmelung
PPTX
Presentation on Epilepsy and Its Animal Models
Gagandeep Jaiswal
PPTX
Local & General Anaesthetics By -Janhavi Burade
Drx Burade
PPTX
Screening of anti seizure drugs
kopalsharma85
PPTX
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
聴sa Badur
PPTX
Final poster 1
AFor1991
PPTX
anticonvulsion
swarupma singh
PPTX
Kishan singh
Kishan Singh
PPTX
Screening of anti seizure drugs
SMS Medical College
PPTX
Expt 12 Anticonvulsant effect of drugs by MES and PTZ method
Mirza Anwar Baig
PPT
screening model for parkinsons disease
Kundlik Rathod
PPTX
Screening of neuromuscular blocking agents
Arijit Chakraborty
PPTX
Aminal models for seizure
Jitendra Agrawal
PPTX
Evaluation of Anti-Epileptic Drugs
Dr. Shivesh Gupta
PPTX
Evaluation Of anti-epileptic activity of Psidium Gujava Extract
Anne Aparajitha
PDF
screening model of Parkinson's disease
uni. inst. of pharmacy c.s.j.m university, kanpur
PPTX
Screening models of antiepileptic and nootropic drugs
HimikaRathi
PPT
Kisspeptin || Ajith hudedh.
Ajith hudedh
PPTX
Screening hypnotic activity
Dr. Pooja
Evaluation of anti epileptic drugs practical
Akshil Mehta
Gralise (Gabapentin ER)
KyleAmelung
Presentation on Epilepsy and Its Animal Models
Gagandeep Jaiswal
Local & General Anaesthetics By -Janhavi Burade
Drx Burade
Screening of anti seizure drugs
kopalsharma85
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
聴sa Badur
Final poster 1
AFor1991
anticonvulsion
swarupma singh
Kishan singh
Kishan Singh
Screening of anti seizure drugs
SMS Medical College
Expt 12 Anticonvulsant effect of drugs by MES and PTZ method
Mirza Anwar Baig
screening model for parkinsons disease
Kundlik Rathod
Screening of neuromuscular blocking agents
Arijit Chakraborty
Aminal models for seizure
Jitendra Agrawal
Evaluation of Anti-Epileptic Drugs
Dr. Shivesh Gupta
Evaluation Of anti-epileptic activity of Psidium Gujava Extract
Anne Aparajitha
screening model of Parkinson's disease
uni. inst. of pharmacy c.s.j.m university, kanpur
Screening models of antiepileptic and nootropic drugs
HimikaRathi
Kisspeptin || Ajith hudedh.
Ajith hudedh
Screening hypnotic activity
Dr. Pooja

Similar to Marinus GNX SFN poster 16Nov16 (20)

PPTX
M pharm 1
rinkajuneja1
PPTX
screening methods for Antiepileptic activity
Sravanthi Shetty
PPTX
Generalised Convulsive Status Epilepticus
Pramod Krishnan
PDF
Screening Methods of Anti-epileptic drugs
A. Gowtham Sashtha
PPTX
Epilesy
krushnalomate
PPTX
status epilepticus-management
Vamsi Krishna Koneru
PPTX
New Antiepileptic drugs Dr.Rahul.pptx
Dr. Rahul R. Bhalsinge
PPTX
Introduction, Classification, general mechanism of action and pharmacology of...
Chalapathi institute of pharmaceutical sciences
PPTX
ANTIEPILEPTIC_DRUGS in children amd usagepptx
hasan farah
PPTX
Anticonvulsants
Tandzile Simelane
PPT
Antiepileptic Drugs. (Antiseizure)
Eneutron
PPTX
Emerging therapies in Lennox-Gastaut Syndrome
LGS Foundation
PPT
ANTIEPILEPTIC_DRUGS .pptx
AlexisIbarra11
PPT
ANTIEPILEPTIC_DRUGS - notes from tripathy
RaosinghRamadoss
PPT
ANTIEPILEPTIC_DRUGS .ppt a very useful presentation
DivyaThomas45
PPT
ANTIEPILEPTIC_DRUGS .ppt
ClinicalPharmacist1
PPT
ANTIEPILEPTIC_DRUGS .ppt
HarishGorrepati
PPT
ANTIEPILEPTIC_DRUGS used for prophylaxis and treatment of epilepsy
navyavijayan10
PPT
ANTIEPILEPTIC DRUGS . mechanism of action of convulsion
MsSapnaSapna
PPTX
ANTIEPILEPTIC_DRUGS drugs for epileepsy new.pptx
fathima200097
M pharm 1
rinkajuneja1
screening methods for Antiepileptic activity
Sravanthi Shetty
Generalised Convulsive Status Epilepticus
Pramod Krishnan
Screening Methods of Anti-epileptic drugs
A. Gowtham Sashtha
Epilesy
krushnalomate
status epilepticus-management
Vamsi Krishna Koneru
New Antiepileptic drugs Dr.Rahul.pptx
Dr. Rahul R. Bhalsinge
Introduction, Classification, general mechanism of action and pharmacology of...
Chalapathi institute of pharmaceutical sciences
ANTIEPILEPTIC_DRUGS in children amd usagepptx
hasan farah
Anticonvulsants
Tandzile Simelane
Antiepileptic Drugs. (Antiseizure)
Eneutron
Emerging therapies in Lennox-Gastaut Syndrome
LGS Foundation
ANTIEPILEPTIC_DRUGS .pptx
AlexisIbarra11
ANTIEPILEPTIC_DRUGS - notes from tripathy
RaosinghRamadoss
ANTIEPILEPTIC_DRUGS .ppt a very useful presentation
DivyaThomas45
ANTIEPILEPTIC_DRUGS .ppt
ClinicalPharmacist1
ANTIEPILEPTIC_DRUGS .ppt
HarishGorrepati
ANTIEPILEPTIC_DRUGS used for prophylaxis and treatment of epilepsy
navyavijayan10
ANTIEPILEPTIC DRUGS . mechanism of action of convulsion
MsSapnaSapna
ANTIEPILEPTIC_DRUGS drugs for epileepsy new.pptx
fathima200097
Ad

Marinus GNX SFN poster 16Nov16

  • 1. Adult male Sprague-Dawley rats (10 weeks of age) were pre-implanted with cortical electrodes. Rats were given lithium chloride (127 mg/kg) followed by pilocarpine (50 mg/kg) to induce SE. SE was first identified by presence of large amplitude slow wave EEG activity and then behaviorally using the Racine scale. Racine stage 3 seizures were used as the time-marker for SE onset and subsequent treatment. GNX and diazepam (DZP) were administered via IV bolus injection 15 min after detection of SE onset. In combination studies, DZP was administered just prior to GNX. Seizure magnitude and duration were measured by EEG recordings. EEG power (mV2/Hz) was calculated by fast Fourier Transform, (FFT) in 1 Hz frequency bins from 1 to 96 Hz using ICELUS software. Frequency ranges analyzed: o Delta 0 5 Hz o Theta 5 10 Hz o Beta 10 30 Hz o Gamma-1 30 50 Hz o Gamma-2 50 70 Hz o Gamma-3 70 96 Hz EEG power values for each animal were normalized by subtracting the baseline value from all subsequent values. EEG power data were evaluated by 2-way ANOVA (treatment and time period) at each frequency range using Prism Graphpad (version 6). Post-hoc analysis consisted of Holms-Sidak multiple comparison tests, with significance set at P< 0.05. Ganaxolone (GNX) is the 3硫-methylated analog of the naturally occurring neurosteroid allopregnanolone that is being developed for the treatment of status epilepticus (SE). SE is a severe, life-threatening epileptic condition that is currently treated with benzodiazepines to control SE followed by standard antiepileptic drugs such as phenytoin and then, if needed, by administration of general anesthetics such as propofol. Patients with SE become progressively refractory to treatment over time. Moreover, more than 30% of SE patients are resistant to aggressive benzodiazepine administration. The rat lithium-pilocarpine model of SE is a clinically translatable model of this condition. Rats subjected to experimental SE are refractory to benzodiazepine if treatment is initiated 15 min after seizure onset; thus modeling a treatment resistant form of SE. GNX elicits its antiepileptic activity through positive allosteric modulation of both the synaptic and the extrasynaptic GABAA receptors, unlike benzodiazepines which only modulate the synaptic receptors. The current studies were designed to evaluate the combination antiepileptic effects of GNX with diazepam in a benzodiazepine resistant SE paradigm. Ganaxolone and Diazepam Administered IV Produce a Synergistic Antiepileptic Effect in a Treatment Refractory Model of Status Epilepticus Michael S. Saporito, PhD1, John A. Gruner, PhD2, Julia Tsai, PhD1, and Albena Patroneva, MD1. 1Marinus Pharmaceuticals, Inc, Radnor, PA, United States, 19087; 2 Melior Discovery, Inc. Exton, PA. We have previously demonstrated that GNX when administered alone 15 min after SE onset elicits a complete block of SE at dose-levels of >12 mg/kg Diazepam is inactive up to dose-levels of 10 mg/kg when administered >15 min after SE onset When administered in combination 15 min after SE onset, DZP (5 mg/kg) and GNX (6 mg/kg) elicit a complete block of pilocarpine induced seizures. The pharmacokinetics of GNX and diazepam were identical when administered alone or in combination indicating that neither drug affected the pharmacokinetic disposition of the other. The data suggest that this synergistic enhancement of antiepileptic activity occurred at the level of the GABAA receptor. GNX administered alone in a dose-escalation fashion elicits EEG changes similar to that of propofol. These data have clinical implications in the treatment of SE when GNX is to be administered to patients who are or have been treated with benzodiazepines. Skull Image From Watson, The Rat anchor screw (sinus) Frontal cortex electrodes 3mm ant. to Bregma 2.5mm lateral Hippocampal Electrodes 4mm post. to Bregma 3mm lateral Skull sutures anchor screw (vertex) EEG Ch1 Ch2 Neck Muscles InterauralLine Lambda Bregma Bregma Figure 1. Electrode Placement Figure 2. Status epilepticus was induced by administration of lithium and pilocarpine. DZP (5 mg/kg; IV) or GNX were administered 15 minutes after SE onset. For combinations, DZP and GNX were administered sequentially. Seizures were measured by EEG response. Data are expressed as a EEG power (Log mV2/Hz). Data represent the 10-30 Hz frequency range. Data were analyzed by two-way ANOVA followed by a post-hoc Dunnetts test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 from vehicle control. Figure 2. Ganaxolone Combined with Diazepam Elicits a Synergistic Antiepileptic Effect in Status Epilepticus 0 2 4 6 -1 0 1 2 Time Relative to SE Onset (hrs) EEGPower (LogmV2/Hz) DZP (5 mg/kg) Vehicle Treatment 0 2 4 6 -1 0 1 2 Time Relative to SE Onset (hrs) EEGPower (LogmV2/Hz) Vehicle DZP (5 mg/kg) + GNX (3 mg/kg) DZP (5 mg/kg) + GNX (6 mg/kg) Treatment ** * **** **** ** *** 0 2 4 6 -1 0 1 2 Time Relative to SE Onset (hrs) EEGPower (LogmV2/Hz) GNX (3 mg/kg) GNX (6 mg/kg) Vehicle Treatment SE-onset Vehicle Pilocarpine Treatment Diazepam (5 mg/kg) Ganaxolone (6 mg/kg) Diazepam (5mg/kg) + Ganaxolone (6 mg/kg) SSSSSE-onset EEG Traces SE-onset and Treatment Figure 3. Representative EEG traces of vehicle, diazepam alone (5 mg/kg), GNX alone (6 mg/kg) or diazepam and ganaxolone in combination Figure 4. Diazepam (5 mg/kg) and GNX (6 mg/kg) pharmacokinetics (IV) were measured alone and in combination. For combination, GNX was administered immediately after DZP. Plasma levels were measured by LC/MS/MS. Predose 3 mg/kg 9 mg/kg 15 mg/kg 24 mg/kg 30 mg/kg Propofol 6 sec Ganaxolone Figure 5. In order to evaluate the effects of GNX on normal awake rats, the drug was administered at 3 mg/kg (bolus; IV) every 3 minutes. EEG signal was measured continuously for 6 hours. EEG traces represent 6 seconds beginning 2 min after the injection. EEG changes are consistent with anesthetic effects and are first detected after the 3rd administration. Figure 3. Diazepam and Ganaxolone Produce a Synergistic Antiepileptic Response Figure 4. Ganaxolone and Diazepam Pharmacokinetics Were Not Altered by Co-administration Figure 5. Ganaxolone Shows Similar Effects to Propofol on EEG OVERVIEW SUMMARY AND CONCLUSIONS 0 20 40 60 80 100 0 500 1000 1500 2000 2500 Diazepam Pharmacokinetics Time (min) Diazepam(ng/mL) DZP (5 mg/kg) GNX (6 mg/kg) + DZP (5 mg/kg) 0 20 40 60 80 100 0 1000 2000 3000 4000 Ganaxolone Pharmacokinetics Time (min) GNXLevels(ng/ml) GNX (6 mg/kg) GNX (6 mg/kg) + DZP (5 mg/kg) METHODS